First Wave Biopharma Engages Rho to Manage Phase II Clinical Trial of Enhanced Adrulipase Formulation

First Wave BioPharma, Inc. announced that it has entered into an agreement with Rho, a full-service contract research organization, for its planned Phase II clinical trial of an enhanced enteric microgranule delivery formulation for adrulipase.